US 10538532
Hepatitis B antiviral agents
granted A61KA61K31/167A61K31/18
Quick answer
US patent 10538532 (Hepatitis B antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/167, A61K31/18, A61K31/196, A61K31/215